Home > Press Releases > Cell Therapy Market

Cell Therapy Market Likely to Surpass ~USD 24 billion by 2035

Report Code: HC-71639  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 289
Get PDF
Buy

Global Cell Therapy Market Forecast 2035:

According to the report, the global cell therapy market is likely to grow from USD 5.3 Billion in 2025 to USD 24.4 Billion in 2035 at a highest CAGR of 16.5% during the time period. The worldwide cell therapy market experiences fast expansion because of rising use of customized and genetically altered treatments combined with the growing incidence of cancer and enduring medical conditions and the development of manufacturing processes which allow for better production capabilities.

Organizations together with medical institutions direct their resources towards CAR‑T and TCR and allogeneic cell therapy development to enhance treatment results and patient treatment results and operational performance. The development of new treatments and their commercial distribution process receives acceleration through regulatory incentives which include RMAT designations and fast-track approval systems.

In 2025, Cellistic introduce three new iPSC-based GMP manufacturing platforms which focus on producing immuno-oncology and regenerative medicine therapies while the industry showed interest in developing systems that deliver scalable production with reliable output. The combination of AI and automation together with digital bioprocessing platforms improves quality control processes while decreasing production expenses and making healthcare services available to more patients and doctors around the world.

Key Driver, Restraint, and Growth Opportunity Shaping the Global Cell Therapy Market

The global cell therapy market grows because medical professionals use cell therapies to treat both regenerative medicine and neurological conditions with advanced stem cell and iPSC-based Parkinson's disease and cardiovascular treatments. The MHLW expert panel in Japan granted conditional approval in September 2025 for first-in-world allogeneic iPSC therapies Amchepry and ReHeart to treat Parkinson's disease and heart failure, which demonstrates progress in regulatory matters and rising need for new treatment options.

The distribution process faces a major obstacle from its complex system which needs many different steps to create and distribute products while maintaining quality standards and spending large amounts of money for cell-based products that include cell growth and genetic engineering. The operational limitations of personalized autologous therapies prevent their affordable distribution to customers while stopping their commercial distribution.

The highest potential opportunity area exists through companies working together to create decentralized production systems combined with bioprocessing systems that use artificial intelligence because this method allows healthcare providers to deliver cell therapies directly to patients while increasing product quality and shortening treatment delivery time. The first hospital-based autologous iPSC Foundry opened its doors when Cellino and Mass General Brigham formed a partnership in February 2025 to use AI-based Nebula technology for personalized treatment delivery at healthcare facilities.

Expansion of Global Cell Therapy Market

Technological Innovation, Advanced Manufacturing, and Strategic Collaborations Driving the Global Cell Therapy Market Expansion

  • The global cell therapy market experiences its most rapid expansion because of technological innovation and advanced manufacturing techniques and business partnerships. The introduction of gene editing and CAR‑T and TCR and iPSC-based platforms enables doctors to create more effective and personalized treatments for cancers and autoimmune diseases and genetic disorders which were previously considered untreatable.
  • The establishment of automated closed-system bioreactors together with AI-based process monitoring and digital twin systems enhances manufacturing capacity while maintaining product quality and safety through contamination control which is essential for developing personalized and allogeneic therapies.
  • Partnerships and collaborations together with joint efforts represent crucial elements for success. The partnership between Kytopen and BlueWhale Bio develops a non-viral continuous manufacturing platform which shortens production times and increases output. The Cellino and Mass General Brigham iPSC Foundry uses AI-based automation to create customized treatments which doctors deliver directly to patients.
  • The APAC partnership between Cell Therapies and ENCell strengthens local manufacturing capabilities which enables better access to products while decreasing transportation challenges. The combination of digital supply chain solutions together with predictive analytics and automated quality control systems creates a framework that achieves regulatory compliance while maintaining cost efficiency.
  • The combination of these technological advancements and collaborative efforts and infrastructure funding initiatives results in faster clinical research progress and wider patient access to cell therapies which will establish their commercial success in global markets.

Regional Analysis of Global Cell Therapy Market

  • North America shows the highest demand for cell therapy market because its biotechnology ecosystem operates effectively, cancer and chronic disease rates remain high, and reimbursement systems function correctly. The American Cancer Society reports that almost 50 percent of Americans will receive a cancer diagnosis during their lifetime which drives the need for CAR-T TCR and other immune cell treatments. The fast clinical adoption process receives support from regulatory incentives which include RMAT designations and fast-track approvals.
  • Additionally, North America maintains its dominant position in the global market through its combination of top biopharma companies, complete manufacturing facilities, and high research and development expenditure. The growing number of partnerships between hospitals and academic institutions and contract development and manufacturing organizations (CDMOs) helps hospitals conduct more clinical trials while shortening the development time of new treatments.
  • The increasing use of digital platforms and AI-based process monitoring systems and automated bioprocessing methods helps institutions achieve better therapy results and greater production efficiency which enables more patients to access treatments. North America stands as the foremost global region for cell therapy market implementation because of its expanding digital platform usage and AI process monitoring capabilities and automated bioprocessing methods.
  • Further, the fastest expanding area of cell therapy research currently occurs in the Asia Pacific region because of growing healthcare system digitization and developing clinical trial networks and increasing governmental funding for regenerative medicine research. China and Japan and India have started to establish more manufacturing plants while launching government-sponsored initiatives to make therapies more accessible to patients.
  • Moreover, China granted approval for several allogeneic CAR-T trials in 2025 which allowed lymphoma and leukemia patients to access new treatment options. The Asia Pacific region achieves its position as the most rapidly growing area in worldwide cell therapy markets because of its strategic partnerships with international CDMOs and its increasing investments in domestic biotechnology research.

Prominent players operating in global cell therapy market include prominent companies such as Allogene Therapeutics, Inc., Amgen Inc., Astellas Pharma Inc., Atara Biotherapeutics, Inc., Autolus Therapeutics plc, bluebird bio, Inc., Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, Cellectis S.A., CRISPR Therapeutics AG, Fate Therapeutics, Inc., Gilead Sciences, Inc., Iovance Biotherapeutics, Inc., Johnson & Johnson, JW Therapeutics (Shanghai) Co., Ltd., Legend Biotech Corporation, Mesoblast Limited, Novartis AG, Sangamo Therapeutics, Inc., Vericel Corporation, along with several other key players.

The global cell therapy market has been segmented as follows:

Global Cell Therapy Market Analysis, by Therapy Type

  • Autologous Cell Therapy
  • Allogeneic Cell Therapy

Global Cell Therapy Market Analysis, by Cell Type

  • Stem Cell Therapy
    • Hematopoietic Stem Cells
    • Mesenchymal Stem Cells
    • Embryonic Stem Cells
    • Induced Pluripotent Stem Cells (iPSCs)
  • Immune Cell Therapy
    • T-Cell Therapy
    • CAR-T Cell Therapy
    • Natural Killer (NK) Cell Therapy
    • Dendritic Cell Therapy
  • Other Cell Therapies
    • Fibroblast-Based Therapies
    • Chondrocyte-Based Therapies

Global Cell Therapy Market Analysis, by Technology

  • Somatic Cell Technology
  • Genome Editing Technology
  • Viral Vector Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • 3D Cell Culture Technology
  • Others

Global Cell Therapy Market Analysis, by Therapy Technique

  • Stem Cell Therapy
  • Adoptive Cell Transfer (ACT)
    • CAR-T Cell Therapy
    • T-Cell Receptor (TCR) Therapy
    • Natural Killer (NK) Cell Therapy
  • Cell Vaccine Therapy
  • Fibroblast Cell Therapy
  • Chondrocyte Cell Therapy
  • Others

Global Cell Therapy Market Analysis, by Cell Source

  • Bone Marrow-Derived Cells
  • Umbilical Cord Blood-Derived Cells
  • Adipose Tissue-Derived Cells
  • Placenta-Derived Cells
  • Induced Pluripotent Stem Cells (iPSCs)
  • Neural Stem Cells
  • Others

Global Cell Therapy Market Analysis, by Application

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Dermatology
  • Ophthalmology
  • Autoimmune Diseases
  • Wound Healing and Tissue Repair
  • Others

Global Cell Therapy Market Analysis, by End User

  • Hospitals and Clinics
  • Biopharmaceutical and Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Regenerative Medicine Centers
  • Others

Global Cell Therapy Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Natures
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Natures
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Cell Therapy Market Outlook
      • 2.1.1. Cell Therapy Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of cancer and chronic diseases fueling demand for advanced therapies.
        • 4.1.1.2. Technological innovations in CAR‑T, TCR, and allogeneic cell therapies enhancing efficacy and accessibility.
        • 4.1.1.3. Supportive regulatory frameworks and expedited approval pathways accelerating development and commercialization.
      • 4.1.2. Restraints
        • 4.1.2.1. High manufacturing complexity and costs limiting large-scale adoption.
        • 4.1.2.2. Stringent quality control and compliance requirements slowing production and scalability.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Cell Therapy Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Cell Therapy Market Analysis, by Therapy Type
    • 6.1. Key Segment Analysis
    • 6.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapy Type, 2021-2035
      • 6.2.1. Autologous Cell Therapy
      • 6.2.2. Allogeneic Cell Therapy
  • 7. Global Cell Therapy Market Analysis, by Cell Type
    • 7.1. Key Segment Analysis
    • 7.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Cell Type, 2021-2035
      • 7.2.1. Stem Cell Therapy
        • 7.2.1.1. Hematopoietic Stem Cells
        • 7.2.1.2. Mesenchymal Stem Cells
        • 7.2.1.3. Embryonic Stem Cells
        • 7.2.1.4. Induced Pluripotent Stem Cells (iPSCs)
      • 7.2.2. Immune Cell Therapy
        • 7.2.2.1. T-Cell Therapy
        • 7.2.2.2. CAR-T Cell Therapy
        • 7.2.2.3. Natural Killer (NK) Cell Therapy
        • 7.2.2.4. Dendritic Cell Therapy
      • 7.2.3. Other Cell Therapies
        • 7.2.3.1. Fibroblast-Based Therapies
        • 7.2.3.2. Chondrocyte-Based Therapies
  • 8. Global Cell Therapy Market Analysis, by Technology
    • 8.1. Key Segment Analysis
    • 8.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 8.2.1. Somatic Cell Technology
      • 8.2.2. Genome Editing Technology
      • 8.2.3. Viral Vector Technology
      • 8.2.4. Cell Immortalization Technology
      • 8.2.5. Cell Plasticity Technology
      • 8.2.6. 3D Cell Culture Technology
      • 8.2.7. Others
  • 9. Global Cell Therapy Market Analysis, by Therapy Technique
    • 9.1. Key Segment Analysis
    • 9.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapy Technique, 2021-2035
      • 9.2.1. Stem Cell Therapy
      • 9.2.2. Adoptive Cell Transfer (ACT)
        • 9.2.2.1. CAR-T Cell Therapy
        • 9.2.2.2. T-Cell Receptor (TCR) Therapy
        • 9.2.2.3. Natural Killer (NK) Cell Therapy
      • 9.2.3. Cell Vaccine Therapy
      • 9.2.4. Fibroblast Cell Therapy
      • 9.2.5. Chondrocyte Cell Therapy
      • 9.2.6. Others
  • 10. Global Cell Therapy Market Analysis, by Cell Source
    • 10.1. Key Segment Analysis
    • 10.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Cell Source, 2021-2035
      • 10.2.1. Bone Marrow-Derived Cells
      • 10.2.2. Umbilical Cord Blood-Derived Cells
      • 10.2.3. Adipose Tissue-Derived Cells
      • 10.2.4. Placenta-Derived Cells
      • 10.2.5. Induced Pluripotent Stem Cells (iPSCs)
      • 10.2.6. Neural Stem Cells
      • 10.2.7. Others
  • 11. Global Cell Therapy Market Analysis, by Application
    • 11.1. Key Segment Analysis
    • 11.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 11.2.1. Oncology
      • 11.2.2. Cardiovascular Diseases
      • 11.2.3. Neurological Disorders
      • 11.2.4. Musculoskeletal Disorders
      • 11.2.5. Dermatology
      • 11.2.6. Ophthalmology
      • 11.2.7. Autoimmune Diseases
      • 11.2.8. Wound Healing and Tissue Repair
      • 11.2.9. Others
  • 12. Global Cell Therapy Market Analysis, by End User
    • 12.1. Key Segment Analysis
    • 12.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 12.2.1. Hospitals and Clinics
      • 12.2.2. Biopharmaceutical and Biotechnology Companies
      • 12.2.3. Research Institutes
      • 12.2.4. Contract Research Organizations (CROs)
      • 12.2.5. Regenerative Medicine Centers
      • 12.2.6. Others
  • 13. Global Cell Therapy Market Analysis and Forecasts, by Region
    • 13.1. Key Findings
    • 13.2. Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 13.2.1. North America
      • 13.2.2. Europe
      • 13.2.3. Asia Pacific
      • 13.2.4. Middle East
      • 13.2.5. Africa
      • 13.2.6. South America
  • 14. North America Cell Therapy Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. North America Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Therapy Type
      • 14.3.2. Cell Type
      • 14.3.3. Technology
      • 14.3.4. Therapy Technique
      • 14.3.5. Cell Source
      • 14.3.6. Application
      • 14.3.7. End User
      • 14.3.8. Country
        • 14.3.8.1. USA
        • 14.3.8.2. Canada
        • 14.3.8.3. Mexico
    • 14.4. USA Cell Therapy Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Therapy Type
      • 14.4.3. Cell Type
      • 14.4.4. Technology
      • 14.4.5. Therapy Technique
      • 14.4.6. Cell Source
      • 14.4.7. Application
      • 14.4.8. End User
    • 14.5. Canada Cell Therapy Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Therapy Type
      • 14.5.3. Cell Type
      • 14.5.4. Technology
      • 14.5.5. Therapy Technique
      • 14.5.6. Cell Source
      • 14.5.7. Application
      • 14.5.8. End User
    • 14.6. Mexico Cell Therapy Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Therapy Type
      • 14.6.3. Cell Type
      • 14.6.4. Technology
      • 14.6.5. Therapy Technique
      • 14.6.6. Cell Source
      • 14.6.7. Application
      • 14.6.8. End User
  • 15. Europe Cell Therapy Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Europe Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Therapy Type
      • 15.3.2. Cell Type
      • 15.3.3. Technology
      • 15.3.4. Therapy Technique
      • 15.3.5. Cell Source
      • 15.3.6. Application
      • 15.3.7. End User
      • 15.3.8. Country
        • 15.3.8.1. Germany
        • 15.3.8.2. United Kingdom
        • 15.3.8.3. France
        • 15.3.8.4. Italy
        • 15.3.8.5. Spain
        • 15.3.8.6. Netherlands
        • 15.3.8.7. Nordic Countries
        • 15.3.8.8. Poland
        • 15.3.8.9. Russia & CIS
        • 15.3.8.10. Rest of Europe
    • 15.4. Germany Cell Therapy Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Therapy Type
      • 15.4.3. Cell Type
      • 15.4.4. Technology
      • 15.4.5. Therapy Technique
      • 15.4.6. Cell Source
      • 15.4.7. Application
      • 15.4.8. End User
    • 15.5. United Kingdom Cell Therapy Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Therapy Type
      • 15.5.3. Cell Type
      • 15.5.4. Technology
      • 15.5.5. Therapy Technique
      • 15.5.6. Cell Source
      • 15.5.7. Application
      • 15.5.8. End User
    • 15.6. France Cell Therapy Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Therapy Type
      • 15.6.3. Cell Type
      • 15.6.4. Technology
      • 15.6.5. Therapy Technique
      • 15.6.6. Cell Source
      • 15.6.7. Application
      • 15.6.8. End User
    • 15.7. Italy Cell Therapy Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Therapy Type
      • 15.7.3. Cell Type
      • 15.7.4. Technology
      • 15.7.5. Therapy Technique
      • 15.7.6. Cell Source
      • 15.7.7. Application
      • 15.7.8. End User
    • 15.8. Spain Cell Therapy Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Therapy Type
      • 15.8.3. Cell Type
      • 15.8.4. Technology
      • 15.8.5. Therapy Technique
      • 15.8.6. Cell Source
      • 15.8.7. Application
      • 15.8.8. End User
    • 15.9. Netherlands Cell Therapy Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Therapy Type
      • 15.9.3. Cell Type
      • 15.9.4. Technology
      • 15.9.5. Therapy Technique
      • 15.9.6. Cell Source
      • 15.9.7. Application
      • 15.9.8. End User
    • 15.10. Nordic Countries Cell Therapy Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Therapy Type
      • 15.10.3. Cell Type
      • 15.10.4. Technology
      • 15.10.5. Therapy Technique
      • 15.10.6. Cell Source
      • 15.10.7. Application
      • 15.10.8. End User
    • 15.11. Poland Cell Therapy Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Therapy Type
      • 15.11.3. Cell Type
      • 15.11.4. Technology
      • 15.11.5. Therapy Technique
      • 15.11.6. Cell Source
      • 15.11.7. Application
      • 15.11.8. End User
    • 15.12. Russia & CIS Cell Therapy Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Therapy Type
      • 15.12.3. Cell Type
      • 15.12.4. Technology
      • 15.12.5. Therapy Technique
      • 15.12.6. Cell Source
      • 15.12.7. Application
      • 15.12.8. End User
    • 15.13. Rest of Europe Cell Therapy Market
      • 15.13.1. Country Segmental Analysis
      • 15.13.2. Therapy Type
      • 15.13.3. Cell Type
      • 15.13.4. Technology
      • 15.13.5. Therapy Technique
      • 15.13.6. Cell Source
      • 15.13.7. Application
      • 15.13.8. End User
  • 16. Asia Pacific Cell Therapy Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Asia Pacific Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Therapy Type
      • 16.3.2. Cell Type
      • 16.3.3. Technology
      • 16.3.4. Therapy Technique
      • 16.3.5. Cell Source
      • 16.3.6. Application
      • 16.3.7. End User
      • 16.3.8. Country
        • 16.3.8.1. China
        • 16.3.8.2. India
        • 16.3.8.3. Japan
        • 16.3.8.4. South Korea
        • 16.3.8.5. Australia and New Zealand
        • 16.3.8.6. Indonesia
        • 16.3.8.7. Malaysia
        • 16.3.8.8. Thailand
        • 16.3.8.9. Vietnam
        • 16.3.8.10. Rest of Asia Pacific
    • 16.4. China Cell Therapy Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Therapy Type
      • 16.4.3. Cell Type
      • 16.4.4. Technology
      • 16.4.5. Therapy Technique
      • 16.4.6. Cell Source
      • 16.4.7. Application
      • 16.4.8. End User
    • 16.5. India Cell Therapy Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Therapy Type
      • 16.5.3. Cell Type
      • 16.5.4. Technology
      • 16.5.5. Therapy Technique
      • 16.5.6. Cell Source
      • 16.5.7. Application
      • 16.5.8. End User
    • 16.6. Japan Cell Therapy Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Therapy Type
      • 16.6.3. Cell Type
      • 16.6.4. Technology
      • 16.6.5. Therapy Technique
      • 16.6.6. Cell Source
      • 16.6.7. Application
      • 16.6.8. End User
    • 16.7. South Korea Cell Therapy Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Therapy Type
      • 16.7.3. Cell Type
      • 16.7.4. Technology
      • 16.7.5. Therapy Technique
      • 16.7.6. Cell Source
      • 16.7.7. Application
      • 16.7.8. End User
    • 16.8. Australia and New Zealand Cell Therapy Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Therapy Type
      • 16.8.3. Cell Type
      • 16.8.4. Technology
      • 16.8.5. Therapy Technique
      • 16.8.6. Cell Source
      • 16.8.7. Application
      • 16.8.8. End User
    • 16.9. Indonesia Cell Therapy Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Therapy Type
      • 16.9.3. Cell Type
      • 16.9.4. Technology
      • 16.9.5. Therapy Technique
      • 16.9.6. Cell Source
      • 16.9.7. Application
      • 16.9.8. End User
    • 16.10. Malaysia Cell Therapy Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Therapy Type
      • 16.10.3. Cell Type
      • 16.10.4. Technology
      • 16.10.5. Therapy Technique
      • 16.10.6. Cell Source
      • 16.10.7. Application
      • 16.10.8. End User
    • 16.11. Thailand Cell Therapy Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Therapy Type
      • 16.11.3. Cell Type
      • 16.11.4. Technology
      • 16.11.5. Therapy Technique
      • 16.11.6. Cell Source
      • 16.11.7. Application
      • 16.11.8. End User
    • 16.12. Vietnam Cell Therapy Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Therapy Type
      • 16.12.3. Cell Type
      • 16.12.4. Technology
      • 16.12.5. Therapy Technique
      • 16.12.6. Cell Source
      • 16.12.7. Application
      • 16.12.8. End User
    • 16.13. Rest of Asia Pacific Cell Therapy Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Therapy Type
      • 16.13.3. Cell Type
      • 16.13.4. Technology
      • 16.13.5. Therapy Technique
      • 16.13.6. Cell Source
      • 16.13.7. Application
      • 16.13.8. End User
  • 17. Middle East Cell Therapy Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Middle East Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Therapy Type
      • 17.3.2. Cell Type
      • 17.3.3. Technology
      • 17.3.4. Therapy Technique
      • 17.3.5. Cell Source
      • 17.3.6. Application
      • 17.3.7. End User
      • 17.3.8. Country
        • 17.3.8.1. Turkey
        • 17.3.8.2. UAE
        • 17.3.8.3. Saudi Arabia
        • 17.3.8.4. Israel
        • 17.3.8.5. Rest of Middle East
    • 17.4. Turkey Cell Therapy Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Therapy Type
      • 17.4.3. Cell Type
      • 17.4.4. Technology
      • 17.4.5. Therapy Technique
      • 17.4.6. Cell Source
      • 17.4.7. Application
      • 17.4.8. End User
    • 17.5. UAE Cell Therapy Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Therapy Type
      • 17.5.3. Cell Type
      • 17.5.4. Technology
      • 17.5.5. Therapy Technique
      • 17.5.6. Cell Source
      • 17.5.7. Application
      • 17.5.8. End User
    • 17.6. Saudi Arabia Cell Therapy Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Therapy Type
      • 17.6.3. Cell Type
      • 17.6.4. Technology
      • 17.6.5. Therapy Technique
      • 17.6.6. Cell Source
      • 17.6.7. Application
      • 17.6.8. End User
    • 17.7. Israel Cell Therapy Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Therapy Type
      • 17.7.3. Cell Type
      • 17.7.4. Technology
      • 17.7.5. Therapy Technique
      • 17.7.6. Cell Source
      • 17.7.7. Application
      • 17.7.8. End User
    • 17.8. Rest of Middle East Cell Therapy Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Therapy Type
      • 17.8.3. Cell Type
      • 17.8.4. Technology
      • 17.8.5. Therapy Technique
      • 17.8.6. Cell Source
      • 17.8.7. Application
      • 17.8.8. End User
  • 18. Africa Cell Therapy Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Africa Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Therapy Type
      • 18.3.2. Cell Type
      • 18.3.3. Technology
      • 18.3.4. Therapy Technique
      • 18.3.5. Cell Source
      • 18.3.6. Application
      • 18.3.7. End User
      • 18.3.8. Country
        • 18.3.8.1. South Africa
        • 18.3.8.2. Egypt
        • 18.3.8.3. Nigeria
        • 18.3.8.4. Algeria
        • 18.3.8.5. Rest of Africa
    • 18.4. South Africa Cell Therapy Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Therapy Type
      • 18.4.3. Cell Type
      • 18.4.4. Technology
      • 18.4.5. Therapy Technique
      • 18.4.6. Cell Source
      • 18.4.7. Application
      • 18.4.8. End User
    • 18.5. Egypt Cell Therapy Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Therapy Type
      • 18.5.3. Cell Type
      • 18.5.4. Technology
      • 18.5.5. Therapy Technique
      • 18.5.6. Cell Source
      • 18.5.7. Application
      • 18.5.8. End User
    • 18.6. Nigeria Cell Therapy Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Therapy Type
      • 18.6.3. Cell Type
      • 18.6.4. Technology
      • 18.6.5. Therapy Technique
      • 18.6.6. Cell Source
      • 18.6.7. Application
      • 18.6.8. End User
    • 18.7. Algeria Cell Therapy Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Therapy Type
      • 18.7.3. Cell Type
      • 18.7.4. Technology
      • 18.7.5. Therapy Technique
      • 18.7.6. Cell Source
      • 18.7.7. Application
      • 18.7.8. End User
    • 18.8. Rest of Africa Cell Therapy Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Therapy Type
      • 18.8.3. Cell Type
      • 18.8.4. Technology
      • 18.8.5. Therapy Technique
      • 18.8.6. Cell Source
      • 18.8.7. Application
      • 18.8.8. End User
  • 19. South America Cell Therapy Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. South America Cell Therapy Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Therapy Type
      • 19.3.2. Cell Type
      • 19.3.3. Technology
      • 19.3.4. Therapy Technique
      • 19.3.5. Cell Source
      • 19.3.6. Application
      • 19.3.7. End User
      • 19.3.8. Country
        • 19.3.8.1. Brazil
        • 19.3.8.2. Argentina
        • 19.3.8.3. Rest of South America
    • 19.4. Brazil Cell Therapy Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Therapy Type
      • 19.4.3. Cell Type
      • 19.4.4. Technology
      • 19.4.5. Therapy Technique
      • 19.4.6. Cell Source
      • 19.4.7. Application
      • 19.4.8. End User l
    • 19.5. Argentina Cell Therapy Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Therapy Type
      • 19.5.3. Cell Type
      • 19.5.4. Technology
      • 19.5.5. Therapy Technique
      • 19.5.6. Cell Source
      • 19.5.7. Application
      • 19.5.8. End User
    • 19.6. Rest of South America Cell Therapy Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Therapy Type
      • 19.6.3. Cell Type
      • 19.6.4. Technology
      • 19.6.5. Therapy Technique
      • 19.6.6. Cell Source
      • 19.6.7. Application
      • 19.6.8. End User
  • 20. Key Players/ Company Profile
    • 20.1. Allogene Therapeutics, Inc.
      • 20.1.1. Company Details/ Overview
      • 20.1.2. Company Financials
      • 20.1.3. Key Customers and Competitors
      • 20.1.4. Business/ Industry Portfolio
      • 20.1.5. Product Portfolio/ Specification Details
      • 20.1.6. Pricing Data
      • 20.1.7. Strategic Overview
      • 20.1.8. Recent Developments
    • 20.2. Amgen Inc.
    • 20.3. Astellas Pharma Inc.
    • 20.4. Atara Biotherapeutics, Inc.
    • 20.5. Autolus Therapeutics plc
    • 20.6. bluebird bio, Inc.
    • 20.7. Bristol-Myers Squibb Company
    • 20.8. CARsgen Therapeutics Holdings Limited
    • 20.9. Cellectis S.A.
    • 20.10. CRISPR Therapeutics AG
    • 20.11. Fate Therapeutics, Inc.
    • 20.12. Gilead Sciences, Inc.
    • 20.13. Iovance Biotherapeutics, Inc.
    • 20.14. Johnson & Johnson
    • 20.15. JW Therapeutics (Shanghai) Co., Ltd.
    • 20.16. Legend Biotech Corporation
    • 20.17. Mesoblast Limited
    • 20.18. Novartis AG
    • 20.19. Sangamo Therapeutics, Inc.
    • 20.20. Vericel Corporation
    • 20.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation